# Galectin Therapeutics Inc: Form 8-K, filed Dec 20, 2024

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 12:50 ET
- Period: 2024-12-20
- Accession: 0001140361-24-050005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036124050005/ef20040433_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036124050005/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036124050005/ef20040433_8k.htm

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-050005. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.